483
Sandoz Private LimitedSandoz Private Limited – FDA 483, Jul 2, 2024
Record Details
An FDA inspection of Sandoz Private Limited in Navi Mumbai, India, from June 24 to July 2, 2024, identified a significant deficiency in the firm's procedures for preventing objectionable microorganisms in non-sterile drug products. The environmental monitoring program, particularly the microbiological laboratory's practices for capturing contaminants, was found to be inadequate, compromising the accuracy and reliability of results.
View Company Profile
ID · 13edb16e-88f9-4372-b066-5db63f36840b
Other documents for Sandoz Private Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.